InvestorsHub Logo
Followers 284
Posts 43844
Boards Moderated 6
Alias Born 02/22/2005

Re: None

Sunday, 06/11/2006 11:34:32 PM

Sunday, June 11, 2006 11:34:32 PM

Post# of 294
InfinitiStocks.com likes NKTR

NKTR Nektar Therapeutics
June 11: Nektar, the maker of the delivery device for Pfizer's Exubera, said the drug will be launched in the United States in mid-July. Exubera is the first non-invasive inhaled insulin treatment. InfinitiStocks also notes that as of May 10, approximately 20% of the NKTR float is sold short (17 million shares). Price at the time of this alert was $19.71.

http://www.infinitistocks.com

Story:
http://www.alphatradefn.com/story/2006-06-10/BIZ/200606101230BIZWIRE_USPR_____BW5004.html

Good stocks are obvious. Extensive DD is how you convince yourself to buy a bad one.

>^..^<
http://www.investorshub.com/boards/board.asp?board_id=3961

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NKTR News